Ampio Pharmaceuticals Inc. (AMEX:AMPE) closed Thursday at $0.22 per share, down from $0.22 a day earlier. While Ampio Pharmaceuticals Inc. has underperformed by -0.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMPE fell by -96.76%, with highs and lows ranging from $6.85 to $0.20, whereas the simple moving average fell by -74.94% in the last 200 days.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Analysis of Ampio Pharmaceuticals Inc. (AMPE)
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Ampio Pharmaceuticals Inc.’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -96.10% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.20, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and AMPE is recording an average volume of 122.75K. On a monthly basis, the volatility of the stock is set at 15.85%, whereas on a weekly basis, it is put at 9.51%, with a loss of -9.32% over the past seven days.
How Do You Analyze Ampio Pharmaceuticals Inc. Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.50%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 13.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in AMPE shares?
The recent increase in stakes in AMPE appears to be a result of several institutional investors and hedge funds increasing their positions. CVA Family Office LLC’s position in AMPE has decreased by -3.03% in the first quarter. The company now owns 73,567 shares of the stock, with a value of $19201.0, following the sale of -2,295 additional shares during the last quarter. G1 Execution Services LLC made another increased to its shares in AMPE during the first quarter, upping its stake by 760.77%. During the last quarter, the company dropped down 58,868 additional shares for a total stake of worth $17384.0, bringing number of shares owned by the company to 66,606.
During the first quarter, Millennium Management LLC subtracted a -116,600 position in AMPE. Courier Capital LLC purchased an additional 2322.0 shares in the last quarter, increasing its holdings by 6.45%, now holding 38326.0 shares worth $10003.0. At the end of the first quarter, Western Wealth Management LLC increased its AMPE holdings by 5.62% and now holds 24852.0 AMPE shares valued at $6486.0 with the added 1322.0 shares during the period. AMPE shares are owned by institutional investors to the tune of 13.10% at present.
